Back
Speaker illustration

Associate Professor Adam James Nelson

Royal Adelaide Hospital, Adelaide (Australia)

Member of:

European Society of Cardiology

Presentations

Semaglutide for the secondary prevention of cardiovascular disease in people with overweight or obesity, but without diabetes: a cost-effectiveness analysis

Event: ESC Congress 2024

Topic: Health Economics

Session: Mapping cardiovascular health: risk factors, interventions, and geographic insights

Access
Like
Thumbnail

Open discussion with experts on influenza: don’t let influenza break the hearts of your patients!

Event: ESC Congress 2024

Topic: Lipids

Session: Open discussion with experts on Influenza: don’t let influenza break the hearts of your patients!

Access
Like
Thumbnail

Cardiologists' knowledge and perceptions of the seasonal influenza immunisation, Australian perspective

Event: ESC Congress 2024

Topic: Secondary Prevention

Session: Crystal clear - not FLU!

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources